Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis

NCT02917681 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Sao Paulo General Hospital

Collaborators